Skip to content

Price / book at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
2.6×+0.2×
HRO
HarrowHROW
45.7×+28.9×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
3.1×+1.3×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
3.2×-1.2×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
4.9×+3.8×
Vera Therapeutics logo
Vera TherapeuticsVERA
5.7×+2.9×

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Calculated from Kodiak Sciences Inc’s reported figures.

Based on the most recent quarter.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's price / book?
Kodiak Sciences Inc (KOD) reported price / book of 20.8× in Q1 2026.
How has Kodiak Sciences Inc's price / book changed year-over-year?
Kodiak Sciences Inc's price / book increased by 1430.7% year-over-year, from 1.4× to 20.8×.
What is the long-term trend for Kodiak Sciences Inc's price / book?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's price / book has grown at a 4.2% compound annual growth rate (CAGR), from 8.8× to 10.8×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.